Cresco Labs Inc. Adjustments For Depreciation And Amortisation Expense
Cresco Labs Inc. (CRLBF) reported Adjustments For Depreciation And Amortisation Expense of $62.51 million for the 12-month period ending 2023-12-31, per its 40-F filed 2024-03-18.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense · last filed 2024-03-18
| Period end | Adjustments For Depreciation And Amortisation Expense 12 month | Adjustments For Depreciation And Amortisation Expense 12 month as first filed |
|---|---|---|
| 2023-12-31 | $62.51M 40-F · filed 2024-03-18 | |
| 2022-12-31 | $51.93M 40-F · filed 2024-03-18 | |
| 2021-12-31 | $38.64M 40-F · filed 2023-03-22 | |
| 2020-12-31 | $31.79M 40-F · filed 2022-04-05 | $40.02M 40-F/A · filed 2021-04-29 |
| 2019-12-31 | $11.91M 40-F/A · filed 2021-04-29 |